Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M211,629Revenue $M49,605Net Margin (%)18.4Z-Score2.7
Enterprise Value $M212,539EPS $1.4Operating Margin %25.6F-Score6
P/E(ttm))24.3Cash Flow Per Share $3.5Pre-tax Margin (%)24.7Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %2.6Quick Ratio2.4Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %4.4Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %-13.3ROA % (ttm)5.3Higher Current Ratio y-yY
Dividend Yield %3.1Insider Buy (3m)0ROE % (ttm)12.0Less Shares Outstanding y-yY
Payout Ratio %74.0Shares Outstanding M6,129ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEIrving Kahn 2014-12-31 Reduce-0.49%$27.7 - $32.09
($30.23)
$ 34.5312%Reduce -5.14%1,883,217
PFEJean-Marie Eveillard 2014-12-31 Add0.39%$27.7 - $32.09
($30.23)
$ 34.5312%Add 3786.85%5,272,943
PFERichard Pzena 2014-12-31 Buy 0.36%$27.7 - $32.09
($30.23)
$ 34.5312%New holding2,170,568
PFEVanguard Health Care Fund 2014-12-31 Add0.32%$27.7 - $32.09
($30.23)
$ 34.5312%Add 29.88%19,395,622
PFERay Dalio 2014-12-31 Reduce-0.02%$27.7 - $32.09
($30.23)
$ 34.5312%Reduce -28.43%211,208
PFEMichael Price 2014-12-31 Sold Out -0.17%$27.7 - $32.09
($30.26)
$ 34.5312%Sold Out0
PFEIrving Kahn 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 34.5314%Reduce -6.56%1,985,161
PFEMichael Price 2014-09-30 Reduce-0.22%$28.04 - $30.96
($29.58)
$ 34.5314%Reduce -56.02%47,100
PFEJean-Marie Eveillard 2014-09-30 Reduce-0.16%$28.04 - $30.96
($29.58)
$ 34.5314%Reduce -94.11%135,661
PFERay Dalio 2014-09-30 Reduce-0.02%$28.04 - $30.96
($29.58)
$ 34.5314%Reduce -24.91%295,108
PFEHOTCHKIS & WILEY 2014-09-30 Sold Out -0.01%$28.04 - $30.96
($29.58)
$ 34.5314%Sold Out0
PFENWQ Managers 2014-06-30 Reduce-0.81%$29.02 - $32.4
($30.05)
$ 34.5313%Reduce -31.07%6,363,006
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 34.5313%Add 105.23%14,934,022
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 34.5313%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 34.5313%Reduce -70.71%2,303,762
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 34.5313%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 34.5313%Add 5.78%6,075,460
PFERay Dalio 2014-06-30 Add0.06%$29.02 - $32.4
($30.05)
$ 34.5313%Add 250.56%393,008
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01%$29.02 - $32.4
($30.05)
$ 34.5313%Reduce -33.68%128,800
PFEJohn Hussman 2014-06-30 Sold Out -0.04%$29.02 - $32.4
($30.05)
$ 34.5313%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$340.47view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.62-1.33view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.46-0.87view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.73-1.64view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.85-1.98view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.3-0.41view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.23-0.2view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-10Sell9,000$33.781.12view
MADDALUNA ANTHONY JExecutive Vice President 2014-12-08Sell6,500$326.75view
HILL CHARLES HExecutive Vice President 2014-11-10Sell8,285$30.1813.19view

Press Releases about PFE :

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    DE Mar 24 2015 
    Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
    A look at Jean-Marie Eveillard's investment in Pfizer Mar 17 2015 
    Top Pharma Stock Picks For March Mar 13 2015 
    Johnson & Johnson Unfazed By $25 Million Fine Mar 13 2015 
    AbbVie Strikes The Biggest Deal For Treatment Of Cancer Mar 10 2015 
    Pfizer Will Supply Drugs To UNICEF Mar 05 2015 
    Novartis Goes A Step Forward In Treating Lung Cancer Mar 02 2015 
    Lower GDP Estimate Weighs on U.S. Indexes Feb 28 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 


    More From Other Websites
    FactSet: U.S. M&A Activity Dips in February as Private Equity Surges Mar 26 2015
    Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Mar 26 2015
    Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Mar 26 2015
    Employers Boost Wellness Spending 17% From Yoga To Risk Assessments Mar 26 2015
    IPO Stock Watch: CAR-T Maker Cellectis Slips In Debut Mar 25 2015
    Merger momentum keeps on rolling with Heinz deal for Kraft Mar 25 2015
    Merger momentum keeps on rolling with Heinz deal for Kraft Mar 25 2015
    Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD):... Mar 25 2015
    Science, patients driving rare disease drug research surge Mar 25 2015
    Science, patients driving rare disease drug research surge Mar 25 2015
    Pfizer (PFE) Is The 'Chart of the Week' Mar 25 2015
    4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary Mar 25 2015
    Lpath (LPTN) Crumbles on Failure of Kidney Cancer Drug Trial - Analyst Blog Mar 25 2015
    4 Sector Leaders To Boost Your ISA Returns: AstraZeneca plc, Standard Chartered PLC, Bellway plc &... Mar 25 2015
    The 5 Most Shorted NYSE Stocks in March Mar 25 2015
    Merck halts study in light of melanoma drug’s success Mar 24 2015
    Hottest dividend stocks of 2015 Mar 24 2015
    Foreign investors buy UK firms at fastest pace since 2007 Mar 24 2015
    Foreign investors buy UK firms at fastest pace since 2007 Mar 24 2015
    Foreign investors buy UK firms at fastest pace since 2007 Mar 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 9 months ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK